Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)

NCT04558866 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Testosterone Cypionate
DRUG: Darolutamide

Sponsor

Latin American Cooperative Oncology Group

Collaborators

[object Object]